Alert: FDA concerned about two generic ADHD medications
The US Food and Drug Administration (FDA) has announced that it has concerns about whether or not two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release t...

MediGuard Alert: FDA reviews study data for anti-clotting medicines
The US Food and Drug Administration (FDA) is reviewing data from a clinical research study called the Dual Antiplatelet Therapy (DAPT) study comparing the benefits and risks of 30 months versus 12 ...

MediGuard Alert: FDA reviews study data for anti-clotting medicines
The US Food and Drug Administration (FDA) is reviewing data from a clinical research study called the Dual Antiplatelet Therapy (DAPT) study comparing the benefits and risks of 30 months versus 12 ...

Alert: Recall of gabapentin capsules
Aurobindo Pharma USA is voluntarily recalling a single lot of gabapentin capsules 300 mg in 100-count bottles. The affected lot number is GESB14011-A with an expiration date of 12/2015 and has NDC ...

Alert: Report of PML with Tecfidera
The US Food and Drug Administration (FDA) is warning that a patient with multiple sclerosis (MS) who was being treated with Tecfidera (dimethyl fumarate) developed a rare and serious brain infectio...